Montelukast Prescribing at CAMBRIDGE HOUSE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
556
Total Quantity
15.0K
NHS Cost
£712
vs National Avg
-18.8%
CAMBRIDGE HOUSE prescribed 556 items of Montelukast over the last 12 months at a cost of £712 to the NHS. This is 18.8% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
44
Jul 2026
42
Jul 2026
44
Jul 2026
48
Jul 2026
47
Jul 2026
44
Jul 2026
50
Jul 2026
47
Jul 2026
52
Jul 2026
43
Jul 2026
44
Jul 2026
51
Prescribing Details
| Total Items | 556 |
|---|---|
| Total Quantity | 14,952 |
| Total NHS Cost | £712 |
| Presentations | 4 different forms |
| vs National Average | -18.8% |
Montelukast Prescribing Comparison
| This practice | 556 items |
|---|---|
| National average per practice | 685 items |
| Difference | -18.8% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.